Ignite Creation Date:
2024-05-05 @ 4:37 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00288353
Status:
TERMINATED
Last Update Posted:
2017-05-25
First Post:
2006-02-06
Brief Title:
Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic Changes
Sponsor:
Northwestern University
Organization:
Northwestern University
Study Overview
Official Title:
Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic Changes
Status:
TERMINATED
Status Verified Date:
2017-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
unable to secure additional funding
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary goal of this study is to examine the triglycerideHDL ratio and the ischemic EKG changes in patients with schizophrenia schizoaffective disorder or bipolar disorder
Detailed Description:
The primary goal of this study is to examine the triglycerideHDL ratio and the ischemic EKG changes in patients with schizophrenia schizoaffective disorder or bipolar disorder The secondary goal is to identify those subjects in the top tertile for the highest risk of IHD as defined by TGHDL ratios 35 and ischemic EKG changes with and without clinical ischemia eg angina and to see if these risk factors can be reduced or reversed by a change of antipsychotic medication dietary counseling enrollment into available exercise groups etc
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NARSAD | None | None | None |